STOCK TITAN

[8-K] Nutex Health, Inc. Reports Material Event

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Nutex Health, Inc. appointed Michael Bamburg as Chief Operating Officer and disclosed the principal terms of his employment agreement dated September 16, 2025. Bamburg, age 43, joins from HCA Houston Healthcare with a background in payor contracting and provider operations and holds a B.S. in Healthcare Administration and an MBA. The two-year agreement provides a base salary of $415,000 with automatic two-year extensions unless timely notice is given, eligibility for an annual cash bonus up to 60% of base salary, participation in long-term incentive awards valued up to 60% of base salary if granted, and a $100,000 signing bonus payable over four quarters if he remains employed at least 12 months. The agreement includes twelve months' severance and health subsidy if terminated without cause or for good reason, and standard accrual and reimbursement provisions. The filing incorporates the full agreement as Exhibit 10.1.

Nutex Health, Inc. ha nominato Michael Bamburg come Chief Operating Officer e ha reso noti i termini principali del suo contratto di lavoro datato 16 settembre 2025. Bamburg, di 43 anni, arriva da HCA Houston Healthcare, con esperienza in contratti con i pagatori e operazioni dei fornitori, ed è laureato in Amministrazione della Sanità (B.S.) e possiede un MBA. Il contratto quadriennale prevede uno stipendio base di 415.000 USD con estensioni automatiche di due anni a meno che non venga fornita una tempestiva disdetta, l’idoneità a un bonus annuo in contanti fino al 60% dello stipendio base, la partecipazione a premi di incentivazione a lungo termine del valore pari a fino al 60% dello stipendio base se concessi, e un bonus di firma di 100.000 USD pagabile in quattro trimestri se rimane impiegato per almeno 12 mesi. Il contratto comprende dodici mesi di severance e sussidio sanitario in caso di cessazione senza giusta causa o per buone ragioni, oltre a condizioni standard di accrual e rimborso. Il fascicolo incorpora l’intero accordo come Exhibit 10.1.

Nutex Health, Inc. designó a Michael Bamburg como Director Ejecutivo de Operaciones y comunicó los términos principales de su contrato de trabajo fechado el 16 de septiembre de 2025. Bamburg, de 43 años, procede de HCA Houston Healthcare y cuenta con experiencia en contratación de pagadores y operaciones de proveedores; posee una Licenciatura en Administración de la Salud y un MBA. El contrato de dos años prevé un salario base de 415.000 USD con extensiones automáticas de dos_años a menos que se notifique oportunamente; elegibilidad para un bono anual en efectivo de hasta el 60% del salario base; participación en premios de incentivos a largo plazo valorados en hasta el 60% del salario base si se otorgan; y un bono de firma de 100.000 USD pagadero en cuatro trimestres si permanece empleado al menos 12 meses. El acuerdo incluye 12 meses de indemnización y subsidio de salud si se despide sin causa o por buena razón, y disposiciones estándar de acumulación y reembolso. El archivo incorpora el acuerdo completo como Exhibit 10.1.

Nutex Health, Inc.는 Michael Bamburg를 최고 운영책임자(COO)로 임명했고 2025년 9월 16일자 고용계약의 주요 조건을 공개했다. 43세의 Bamburg은 HCA Houston Healthcare에서 근무 경험이 있으며, 보험자 계약 및 공급자 운영 분야의 배경을 가지고 의학 행정학 학사와 MBA를 보유하고 있다. 2년 계약은 기본급 41만 5천 달러를 제공하고, 시기적절한 통지 없이 자동으로 2년 연장이 가능하며, 기본급의 최대 60%에 해당하는 연간 현금 보너스 자격, 필요 시 수여되는 최대 60%의 기본급에 해당하는 장기 인센티브 상여 참여, 그리고 최소 12개월 근무 시 4분기로 분할 지급되는 10만 달러의 서명 보너스를 포함한다. 계약은 해지 사유 없이 해고되거나 정당한 사유로 해고될 경우 12개월의 해고수당 및 건강 보조금을 포함하며, 표준 적립 및 환급 조항을 포함한다. 문서는 Exhibit 10.1로 전체 계약을 첨부한다.

Nutex Health, Inc. a nommé Michael Bamburg au poste de directeur des opérations (COO) et a divulgué les termes principaux de son contrat de travail daté du 16 septembre 2025. Bamburg, âgé de 43 ans, vient de HCA Houston Healthcare et possède une expérience en contractualisation avec les payeurs et en opérations des prestataires; il détient une licence en Administration des soins de santé et un MBA. Le contrat de deux ans prévoit un salaire de base de 415 000 USD, avec des prolongations automatiques de deux ans sauf notification en temps utile, une éligibilité à une prime annuelle en espèces allant jusqu’à 60% du salaire de base, une participation à des récompenses d’incitation à long terme pouvant atteindre 60% du salaire de base si accordées, et une prime de signature de 100 000 USD payable en quatre trimestres s’il reste employé au moins 12 mois. Le contrat comprend douze mois de congédiement et une subvention santé en cas de licenciement sans juste cause ou pour une bonne raison, ainsi que des dispositions standard d’accumulation et de remboursement. Le dossier intègre l’intégralité de l’accord comme Exhibit 10.1.

Nutex Health, Inc. hat Michael Bamburg zum Chief Operating Officer ernannt und die wesentlichen Bedingungen seines am 16. September 2025 datierten Arbeitsvertrags offengelegt. Bamburg, 43 Jahre alt, kommt von HCA Houston Healthcare und verfügt über Erfahrungen in der Vertragshandhabung mit Kostenträgern sowie im Betrieb von Anbietern; er hat einen B.S. in Healthcare Administration und einen MBA. Der zweijährige Vertrag sieht ein Grundgehalt von 415.000 USD vor, mit automatischen Verlängerungen um je zwei Jahre, sofern keine rechtzeitige Kündigung erfolgt, Anspruch auf einen jährlichen Barbonus in Höhe von bis zu 60% des Grundgehalts, Teilnahme an Langzeit-Incentive-Boni bis zu 60% des Grundgehalts, falls gewährt, und einen Signing Bonus von 100.000 USD, der, sofern er mindestens 12 Monate beschäftigt bleibt, über vier Quartale gezahlt wird. Der Vertrag umfasst zwölf Monate Abfindung und einen Gesundheitszuschuss bei Kündigung ohne Grund oder aus wichtigem Grund sowie Standardvorschriften zu Rückstellungen und Erstattungen. Die Unterlagen enthalten die vollständige Vereinbarung als Exhibit 10.1.

قامت شركة Nutex Health, Inc. بتعيين مايكل بامبورغ كمدير تنفيذي للعمليات (COO) وكشفت عن الشروط الأساسية لاتفاقيته الوظيفية المؤرخة في 16 سبتمبر 2025. بامبورغ، البالغ من العمر 43 عامًا، انضم من HCA Houston Healthcare ولديه خبرة في تعاقدات الجهات الدافعة وعمليات مقدمي الخدمات، ويحمل شهادة B.S. في إدارة الرعاية الصحية ودرجة الماجيستير في إدارة الأعمال (MBA). ينص العقد لمدة عامين على راتب أساسي قدره 415,000 دولار مع تمديدات تلقائية لمدة عامين ما لم يتم الإبلاغ بذلك في الوقت المناسب، وأهلية للحصول على مكافأة نقدية سنوية تصل إلى 60% من الراتب الأساسي، والمشاركة في جوائز حوافز طويلة الأجل قيمتها حتى 60% من الراتب الأساسي إذا منحت، ومكافأة توقيع قدرها 100,000 دولار تدفع على أربع فترات إذا بقي في العمل لمدة 12 شهرًا على الأقل. يشمل العقد تعويض فصل لمدة اثني عشر شهرًا ودعمًا صحيًا إذا تم إنهاء العمل دون سبب مشروع أو لسبب وجيه، بالإضافة إلى أحكام قياسية للاستحقاق والتعويض. يضم الملف الاتفاق بالكامل كمعروض Exhibit 10.1.

Nutex Health, Inc. 已任命 Michael Bamburg 为首席运营官(COO),并披露其于 2025 年 9 月 16 日签署的雇佣协议的主要条款。 Bamburg,43 岁,来自 HCA Houston Healthcare,具有对 payer 合同和服务提供者运营的背景,拥有健康护理管理学学士(B.S.)以及工商管理硕士(MBA)。为期两年的协议规定基础薪资为 415,000 美元,若未及时通知则自动延长两年;有资格获得高达基础薪资 60% 的年度现金奖金;如授予则可参与等同于基础薪资 60% 的长期激励奖励;签约奖金为 100,000 美元,若他至少在职 12 个月则分四个季度支付。协议包含 12 个月的解雇补偿及健康补贴(在无因解雇或因合理原因解雇时),并含有标准的计提与报销条款。文件将完整协议作为 Exhibit 10.1 纳入。

Positive
  • Experienced operational hire from HCA with background in payor contracting and provider operations
  • Compensation aligns incentives with up to 60% annual bonus and potential long-term awards up to 60% of base salary
  • Signing bonus structured for retention ($100,000 payable in four quarterly installments subject to 12-month employment)
Negative
  • Automatic two-year contract extensions unless 60-day notice may limit Board flexibility
  • Potential near-term cash cost from base salary, signing bonus installments and severance obligations if terminated without cause

Insights

TL;DR: Routine executive hiring with market-aligned pay and modest severance; automatic renewals reduce Board flexibility.

The appointment formalizes operational leadership with a compensation package typical for mid-market healthcare operators: base salary at $415,000, up to 60% annual bonus potential, and long-term incentive eligibility up to 60% of salary. The automatic two-year extension clause creates rolling terms that could limit near-term governance agility unless either party gives 60-days notice. Severance equal to 12 months' base pay plus health subsidy is moderate and consistent with industry practice. Overall, the disclosure is complete and standard; materiality is limited to personnel and operating expense impact.

TL;DR: Experienced operator hired; compensation and incentives align with operational performance goals.

Bamburg's background at HCA and regional managed-care experience aligns with Nutex's operational needs. The mix of salary, a discretionary bonus tied to company and individual goals, and potential RSUs aims to align his incentives with both short- and long-term performance. The $100,000 signing bonus paid over four quarters with a 12-month retention requirement provides immediate onboarding incentive while limiting long-term payout risk. The filing does not disclose target metrics or estimated P&L impact, so operational effects remain directional rather than quantified.

Nutex Health, Inc. ha nominato Michael Bamburg come Chief Operating Officer e ha reso noti i termini principali del suo contratto di lavoro datato 16 settembre 2025. Bamburg, di 43 anni, arriva da HCA Houston Healthcare, con esperienza in contratti con i pagatori e operazioni dei fornitori, ed è laureato in Amministrazione della Sanità (B.S.) e possiede un MBA. Il contratto quadriennale prevede uno stipendio base di 415.000 USD con estensioni automatiche di due anni a meno che non venga fornita una tempestiva disdetta, l’idoneità a un bonus annuo in contanti fino al 60% dello stipendio base, la partecipazione a premi di incentivazione a lungo termine del valore pari a fino al 60% dello stipendio base se concessi, e un bonus di firma di 100.000 USD pagabile in quattro trimestri se rimane impiegato per almeno 12 mesi. Il contratto comprende dodici mesi di severance e sussidio sanitario in caso di cessazione senza giusta causa o per buone ragioni, oltre a condizioni standard di accrual e rimborso. Il fascicolo incorpora l’intero accordo come Exhibit 10.1.

Nutex Health, Inc. designó a Michael Bamburg como Director Ejecutivo de Operaciones y comunicó los términos principales de su contrato de trabajo fechado el 16 de septiembre de 2025. Bamburg, de 43 años, procede de HCA Houston Healthcare y cuenta con experiencia en contratación de pagadores y operaciones de proveedores; posee una Licenciatura en Administración de la Salud y un MBA. El contrato de dos años prevé un salario base de 415.000 USD con extensiones automáticas de dos_años a menos que se notifique oportunamente; elegibilidad para un bono anual en efectivo de hasta el 60% del salario base; participación en premios de incentivos a largo plazo valorados en hasta el 60% del salario base si se otorgan; y un bono de firma de 100.000 USD pagadero en cuatro trimestres si permanece empleado al menos 12 meses. El acuerdo incluye 12 meses de indemnización y subsidio de salud si se despide sin causa o por buena razón, y disposiciones estándar de acumulación y reembolso. El archivo incorpora el acuerdo completo como Exhibit 10.1.

Nutex Health, Inc.는 Michael Bamburg를 최고 운영책임자(COO)로 임명했고 2025년 9월 16일자 고용계약의 주요 조건을 공개했다. 43세의 Bamburg은 HCA Houston Healthcare에서 근무 경험이 있으며, 보험자 계약 및 공급자 운영 분야의 배경을 가지고 의학 행정학 학사와 MBA를 보유하고 있다. 2년 계약은 기본급 41만 5천 달러를 제공하고, 시기적절한 통지 없이 자동으로 2년 연장이 가능하며, 기본급의 최대 60%에 해당하는 연간 현금 보너스 자격, 필요 시 수여되는 최대 60%의 기본급에 해당하는 장기 인센티브 상여 참여, 그리고 최소 12개월 근무 시 4분기로 분할 지급되는 10만 달러의 서명 보너스를 포함한다. 계약은 해지 사유 없이 해고되거나 정당한 사유로 해고될 경우 12개월의 해고수당 및 건강 보조금을 포함하며, 표준 적립 및 환급 조항을 포함한다. 문서는 Exhibit 10.1로 전체 계약을 첨부한다.

Nutex Health, Inc. a nommé Michael Bamburg au poste de directeur des opérations (COO) et a divulgué les termes principaux de son contrat de travail daté du 16 septembre 2025. Bamburg, âgé de 43 ans, vient de HCA Houston Healthcare et possède une expérience en contractualisation avec les payeurs et en opérations des prestataires; il détient une licence en Administration des soins de santé et un MBA. Le contrat de deux ans prévoit un salaire de base de 415 000 USD, avec des prolongations automatiques de deux ans sauf notification en temps utile, une éligibilité à une prime annuelle en espèces allant jusqu’à 60% du salaire de base, une participation à des récompenses d’incitation à long terme pouvant atteindre 60% du salaire de base si accordées, et une prime de signature de 100 000 USD payable en quatre trimestres s’il reste employé au moins 12 mois. Le contrat comprend douze mois de congédiement et une subvention santé en cas de licenciement sans juste cause ou pour une bonne raison, ainsi que des dispositions standard d’accumulation et de remboursement. Le dossier intègre l’intégralité de l’accord comme Exhibit 10.1.

Nutex Health, Inc. hat Michael Bamburg zum Chief Operating Officer ernannt und die wesentlichen Bedingungen seines am 16. September 2025 datierten Arbeitsvertrags offengelegt. Bamburg, 43 Jahre alt, kommt von HCA Houston Healthcare und verfügt über Erfahrungen in der Vertragshandhabung mit Kostenträgern sowie im Betrieb von Anbietern; er hat einen B.S. in Healthcare Administration und einen MBA. Der zweijährige Vertrag sieht ein Grundgehalt von 415.000 USD vor, mit automatischen Verlängerungen um je zwei Jahre, sofern keine rechtzeitige Kündigung erfolgt, Anspruch auf einen jährlichen Barbonus in Höhe von bis zu 60% des Grundgehalts, Teilnahme an Langzeit-Incentive-Boni bis zu 60% des Grundgehalts, falls gewährt, und einen Signing Bonus von 100.000 USD, der, sofern er mindestens 12 Monate beschäftigt bleibt, über vier Quartale gezahlt wird. Der Vertrag umfasst zwölf Monate Abfindung und einen Gesundheitszuschuss bei Kündigung ohne Grund oder aus wichtigem Grund sowie Standardvorschriften zu Rückstellungen und Erstattungen. Die Unterlagen enthalten die vollständige Vereinbarung als Exhibit 10.1.

0001479681FALSE00014796812025-09-162025-09-16


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
Date of Report (Date of earliest event reported): September 22, 2025 (September 16, 2025)
 
NUTEX HEALTH INC.
(Exact name of registrant as specified in its charter)
 
Delaware001-4134611-3363609
(State or Other Jurisdiction
of Incorporation)
(Commission File Number)(I.R.S. Employer
Identification Number)

6030 S. Rice AveSuite CHoustonTexas 77081
(Address of principal executive offices) (zip code)
 
(713660-0557
(Registrant’s telephone number, including area code)
 
N/A
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   Precommencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   Precommencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbols(s)Name of each exchange on which registered
Common Stock, $0.001 par value
 NUTX
NASDAQ Capital Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.



Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Company’s operations, policies or practices, including accounting principles and practices.
Appointment of Chief Operating Officer
On September 16, 2025 the Board of Directors (the "Board") of Nutex Health, Inc. (the "Company") appointed Mr. Wesley Bamburg to serve as the Company's Chief Operating Officer, effective on or about October 13, 2025 (the “Commencement Date”).
The appointment of Mr. Bamburg follows the previously announced departure of Joshua DeTillio, which was disclosed in the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on July 11, 2025.
Mr. Bamburg, age 43, previously served as Chief Operating Officer for HCA Houston Healthcare North Cypress since July 2024. Before that, from 2019 to 2024, Mr. Bamburg was Chief Operating Officer at HCA Houston Healthcare Medical Center, Houston, TX. Mr. Bamburg began his career with HCA Healthcare in 2013 as the Gulf Coast Division's Vice President (VP) of Payor Contracting & Alignment. Prior to joining HCA Healthcare, Mr. Bamburg had the unique opportunity to work regionally in 11 states, concentrating in managed care, network operations and physician alignment with combined experience from both the payor and provider perspective.
Mr. Bamburg attended Southwestern Oklahoma State University on an athletic scholarship where he earned his Bachelor’s Degree in Healthcare Administration and his Master of Business Administration from Oklahoma City University. He is board-certified in healthcare management and recognized as a Fellow of the American College of Healthcare Executives.
In connection with his appointment as the Company’s Chief Operating Officer, on September 16, 2025, the Company entered into a two (2) year employment agreement with Mr. Bamburg (the "Bamburg Agreement”) pursuant to which Mr. Bamburg is entitled to receive a base annual salary of $415,000, subject to annual review by the Company’s CEO and Board of Directors. The employment agreement contains automatic two-year extensions at the end of each term unless 60-day advance notice of non-extension is delivered by either party.
In the event the Company (or its successor) terminates Mr. Bamburg's employment without cause or Mr. Bamburg resigns for good reason, severance benefits would be twelve months of base monthly salary and a cash subsidy for group medical, dental and vision programs for twelve months. No severance is payable under the Bamburg Agreement if Mr. Bamburg’s employment is terminated by the Company for cause (as defined in the Bamburg Agreement), Mr. Bamburg resigns without good reason (as defined in the Bamburg Agreement) or is unable to perform due to death or disability. Mr. Bamburg is entitled to receive payment of all salary and benefits accrued up to the termination date of his employment upon any termination of employment, unpaid expense reimbursements, and accrued but unused paid time off within thirty (30) days.
Mr. Bamburg will also be eligible to receive an annual cash bonus (the "Annual Bonus”) in an amount of up to sixty percent (60%) of his Base Salary. The Annual Bonus will be recommended by the CEO at his discretion and approved by the Company's Board of Directors. The Annual Bonus shall be based on a combination of Company-wide and Employee-specific goals, both qualitative and quantitative, to be developed and approved by the CEO and Board of Directors each year.
Mr. Bamburg shall be eligible to participate in the Company’s long-term incentive plan that may be available to similarly positioned executives and in the event RSUs’ are awarded, such award may be valued up to sixty percent (60%) of his Base Salary.
Mr. Bamburg will receive an additional cash compensation of $100,000 as a signing bonus, payable in four equal quarterly payments of $25,000, provided Mr. Bamburg remains in employment with the Company for a minimum of twelve months.
The foregoing description of the Bamburg Agreement is not complete and is qualified in its entirety by the full text of the Bamburg Agreement, a copy of which is filed herewith as Exhibit 10.1 and incorporated herein by reference.
There are no other arrangements or understandings between Mr. Bamburg and any other persons pursuant to which Mr. Bamburg was named Chief Operating Officer. Mr. Bamburg does not have any family relationship with any of the Company’s directors or executive officers or any persons nominated or chosen by the Company to be a director or



executive officer. Mr. Bamburg does not have any direct or indirect interest in any transaction or proposed transaction required to be reported under Item 404(a) of Regulation S-K.
Item 7.01 Regulation FD Disclosure.
A copy of the Company’s press release announcing Mr. Bamburg’s appointment is furnished with this Current Report on Form 8-K as Exhibit 99.1.
The information in this Item 7.01 (including Exhibit 99.1) shall not be deemed to be "filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
Exhibit No.
Description of Exhibit
10.1
Employment Agreement, executed as of September 16, 2025 between the Company and Wesley Bamburg
99.1
Press Release dated September 22, 2025
104
Cover Page Interactive Data File - the cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.



SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
Date: September 22, 2025
Nutex Health Inc.
By: /s/ Jon C. Bates
Jon C. Bates
Chief Financial Officer


FAQ

Who was appointed COO of Nutex Health (NUTX)?

Michael Bamburg was appointed Chief Operating Officer according to the 8-K disclosure.

What is Michael Bamburg's base salary at Nutex Health?

$415,000 per year, subject to annual review by the CEO and Board.

What bonus and equity incentives does the Bamburg Agreement provide?

Annual cash bonus up to 60% of base salary (discretionary) and eligibility for long-term incentive awards valued up to 60% of base salary if RSUs are granted.

Does Bamburg's employment agreement include severance?

Yes: if terminated without cause or he resigns for good reason, he is entitled to 12 months of base salary and a 12-month cash subsidy for group medical, dental and vision.

Is the signing bonus immediate?

$100,000 signing bonus is payable in four equal quarterly payments of $25,000, contingent on remaining employed for at least 12 months.
Nutex Health Inc

NASDAQ:NUTX

NUTX Rankings

NUTX Latest News

NUTX Latest SEC Filings

NUTX Stock Data

569.57M
3.57M
35.81%
32.18%
20.07%
Medical Care Facilities
Services-business Services, Nec
Link
United States
HOUSTON